Researchers Identified Potential Marburg Virus Inhibitor
A new computational study found that rutin may target the Marburg virus, though researchers note significant challenges remain.
Updated on Sept. 25, 2026 in Nutrition
Scientists have identified rutin, a compound derived from basil, as a potential inhibitor of the Marburg virus VP40 protein. The discovery emerged from a computational screening of 156 bioactive compounds, marking a step in the search for treatments for this disease.
Why it matters
Marburg virus disease currently lacks any approved antiviral treatment, leaving researchers to seek new drug candidates. This finding identifies a starting point for potential therapies, though extensive work is required to overcome current pharmacokinetic limitations.
A 500 ns molecular dynamics simulation confirmed the stability of the VP40-rutin complex following an in silico screening of 156 bioactive compounds. While the docking score was -10.4 kcal/mol, the study found the compound violates three of Lipinski's criteria for drug-likeness.
The details
The researchers used computer-based docking models and molecular dynamics simulations to analyze how rutin interacts with the Marburg virus VP40 protein. By calculating end-state binding free energies through solvation models, they determined the stability of the molecular bond. However, the compound faces hurdles, including a low predicted human intestinal absorption of 23.45 percent and a gas-phase HOMO-LUMO gap of 4.13 eV, which indicates it requires significant optimization.
Timeline
September 25, 2026: Computational analysis results were published.
Health Landscape
This study sits within the ongoing, global search for the first approved antiviral treatments for the Marburg virus disease. It adds a new computational candidate to the research pipeline while highlighting the technical hurdles that often face drug development for high-risk pathogens.
This development is a preliminary computational finding and does not offer any immediate changes to diet or medical treatment for the public. If you have concerns about infectious disease risks or travel health, consult with your doctor or a travel medicine specialist.
The takeaway
This computational study shows that rutin has potential as a starting point for future Marburg virus research. Keep in mind that initial in silico findings are early-stage and not clinical treatments; follow major public health alerts for the most reliable updates on virus prevention.
Further reading
For more information on how current research explores compounds in food for potential therapeutic applications, visit Nutrition.
Source note: This article includes information reported by Nature.
